Market Access Where Gross-to-net Pressure Actually Lives After Launch Drug ChannelsToday's guest post comes from Cindy Baksh, Chief Product Officer at ConnectiveRx.Read full story pharminent May 1, 2026 (Last updated: May 1, 2026) Drug Channels Today’s guest post comes from Cindy Baksh, Chief Product Officer at ConnectiveRx. Read full story Post navigation Previous: Two biotechs raise a combined $556M in latest spurt of IPOsNext: BMS brings the buzz around late-stage readouts amid a so-so Q1 Related Stories Market Access How cost and perception could reshape the GLP-1 market pharminent August 21, 2026 Market Access D.C. Circuit Affirms HHS Authority Over 340B Rebate Models pharminent July 24, 2026 Market Access NICE aims to cut funding for Amgen lung cancer drug Lumykras pharminent July 9, 2026
